Key result
Second-sample CRP links to ~91% higher odds of hsPDA, outperforming hemogram-derived inflammatory indices.
Why the study?
It was unknown whether hemogram-derived systemic inflammatory indices carry information beyond gestational age and routinely measured C-reactive protein, or whether their temporal trajectory differs in infants with hemodynamically significant patent ductus arteriosus.
Do hemogram-derived systemic inflammatory indices improve discrimination of hemodynamically significant patent ductus arteriosus compared to C-reactive protein and gestational age in infants undergoing echocardiographic evaluation?
Cohort (n=79)
No
Do hemogram-derived systemic inflammatory indices improve discrimination of hemodynamically significant patent ductus arteriosus compared to C-reactive protein and gestational age in infants undergoing echocardiographic evaluation?
In infants evaluated for patent ductus arteriosus, hemogram-derived inflammatory indices offer no independent diagnostic value beyond C-reactive protein and gestational age, and neither biomarker serves as an advance predictor of hemodynamic significance.
Answers are grounded in this paper and cite their sources.
Hemogram indices add no value for hsPDA diagnosis beyond CRP; leaves open their utility and should not yet change practice.
Background: Ductal patency in preterm infants is partly inflammation-driven, and hemogram-derived systemic inflammatory indices have been proposed as accessible markers of a hemodynamically significant patent ductus arteriosus (hsPDA). Whether these indices carry information beyond gestational age and routinely measured C-reactive protein (CRP), and whether their temporal trajectory differs in hsPDA, are unknown, particularly in real-world cohorts evaluated for hsPDA across a broad gestational-age range. Methods: In this single-center retrospective cohort, 79 infants of 24–40 weeks’ gestation (including 10 born at term) undergoing echocardiographic evaluation of the ductus (December 2024–July 2026) had complete blood counts and CRP at two predefined windows (0–48 h and 48–120 h). Six indices (NLR, PLR, MLR, SII, SIRI, PIV) and their between-sampling change were compared by hsPDA status (diameter ≥ 1.5 mm, LA/Ao > 1.4, unrestrictive left-to-right flow), with Benjamini–Hochberg correction, ROC analysis, and gestational-age-adjusted logistic models including CRP. Results: Thirty-six infants (45.6%) had hsPDA. No first-sample index differed between groups (all p > 0.7; AUC 0.48–0.51). At the second sampling, NLR (p = 0.009), SIRI (p = 0.007), and MLR (p = 0.031) were higher in hsPDA, as was the between-sampling change in MLR (ΔMLR, p = 0.006); however, no index remained significant after multiplicity correction (smallest q = 0.057), and none of these differences persisted in samples drawn before treatment. Second-sample CRP was the strongest discriminator (AUC 0.894, 95% CI 0.815–0.960). After adjustment for gestational age and surfactant therapy (Firth regression), CRP remained independently associated with hsPDA (OR 1.91 per doubling, 95% CI 1.47–2.68), whereas MLR did not (OR 1.07 per SD, 95% CI 0.60–2.44). Conclusions: In infants of mixed gestational age evaluated for ductal patency, CRP measured around the time of diagnosis discriminated hsPDA better than all six hemogram-derived indices, which carried no information independent of CRP or respiratory illness severity. CRP rose concurrently with, rather than ahead of, hemodynamic significance, and its signal lay largely at the low end of the measurable range; neither CRP nor the indices should be regarded as predictors of hsPDA.
No takes yet. Share an insight, caveat, or question.
Azizoğlu et al. (2026) conducted a cohort in Hemodynamically significant patent ductus arteriosus (hsPDA) (n=79). C-reactive protein (CRP) vs. Six hemogram-derived inflammatory indices (NLR, PLR, MLR, SII, SIRI, PIV) was evaluated on Hemodynamically significant patent ductus arteriosus (hsPDA: diameter >= 1.5 mm, LA/Ao > 1.4, unrestrictive left-to-right flow) (OR 1.91, 95% CI 1.47-2.68). Second-sample CRP discriminated hsPDA better than six hemogram-derived inflammatory indices, none of which remained significant after multiplicity correction.
Synapse has enriched 10 related papers. Consider them for comparative context: